CEO: Mark Pruzanski

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need.


Key numbers

Market Capitalization:2692289250
Shares Outstanding: 32732999.999999996
Float: 25204933.728
Next Earning Date:2020-02-25
TTm EPS: -10.8726
TTm Dividend Rate:
200 days moving average:82.76
50 days moving average: 69.61
One day percent Change: 11.92



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,